MentionFox
Home › Executive changes › Treace Medical Concepts, Inc.
Leadership changes · SEC Form 8-K, Item 5.02

Treace Medical Concepts, Inc. executive changes

Every leadership change Treace Medical Concepts, Inc. reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings1
Appointments named1
Departures named1
Latest filing2026-04-09

Treace Medical Concepts, Inc. filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-04-09. Between them they name 1 person, with 1 appointment and 1 departure. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-04-09 · 8-K

Departing: Gaetano M. Guglielmino, Chief Commercial Officer, effective 2026-04-08

Effective as of the close of business on April 8, 2026, Gaetano M. Guglielmino, Chief Commercial Officer of Treace Medical Concepts, Inc. (the "Company"), will depart from the Company.

Appointed: Gaetano M. Guglielmino, effective 2026-04-09

In order to assist with the transition of his responsibilities, Mr. Guglielmino entered into a Consulting Services Agreement with the Company, effective as of April 9, 2026, that provides, among other things, that Mr. Guglielmino will serve as an independent consultant to the Company through January 31, 2027.
Hiring for a seat like this?

Find people with the same kind of experience as the Chief Commercial Officer at Treace Medical Concepts, Inc., with the record behind each one.

Find candidates like Chief Commercial Officer at Treace Medical Concepts, Inc.
Selling to Treace Medical Concepts, Inc.?

New leaders review vendors and budgets in their first months. Get an alert the next time Treace Medical Concepts, Inc. is in the news or changes leadership.

Get an alert when Treace Medical Concepts, Inc. changes leadership

Tools for this story

Each opens in a new tab, filled in for Treace Medical Concepts, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/treace-medical-concepts
Last updated 2026-09-27
Primary record: SEC filing
Treace Medical Concepts, Inc. (TMCI) executive changes: Gaetano M. Guglielmino departs, Chief Commercial Officer. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/treace-medical-concepts